Jintanat Ananworanich

Jintanat Ananworanich

Projects

Jintanat Ananworanich

  • Professor of Internal Medicine, Department of Global Health, Amsterdam UMC, University of Amsterdam

Dr. Jintanat Ananworanich is a pediatrician and clinical immunologist. She possesses a broad background in translational medicine and research in low-middle-income settings. Dr. Ananworanich’s primary research interests are in acute HIV infection, early treatment, neuro AIDS, and HIV cure. For two decades, she conducted research at the Thai Red Cross AIDS Research Center and subsequently the US Military HIV Research Program on acute HIV infection, neuro AIDS and HIV cure. She now has published more than 350 articles in the field of HIV, ranging from basic science to clinical trials to public health epidemiology, and across the age span from infants to adults.

For the past three years, Dr. Ananworanich has joined the biotech industry in Cambridge, Massachusetts to develop respiratory vaccines and antibodies, first at the Bill and Melinda Gates Medical Research Institute, and currently at Moderna as their senior clinical lead for the influenza vaccine program. She is currently a Professor of Global Health at the AIGHD and the University of Amsterdam.

View Jintanat’s publications (PubMed)

KEY PUBLICATIONS

Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology.
de Souza MS, Pinyakorn S, Akapirat S, Pattanachaiwit S, Fletcher JL, Chomchey N, Kroon ED, Ubolyam S, Michael NL, Robb ML, Phanuphak P, Kim JH, Phanuphak N, Ananworanich J; RV254/SEARCH010 Study Group.
Clin Infect Dis. 2016 Aug 15;63(4):555-61. doi: 10.1093/cid/ciw365.
Epub 2016 Jun 17.PMID: 27317797

International AIDS Society global scientific strategy: towards an HIV cure 2016.
Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D, Margolis D, Mellors J, Persaud D, Tucker JD, Barre-Sinoussi F; International AIDS Society Towards a Cure Working Group, Alter G, Auerbach J, Autran B, Barouch DH, Behrens G, Cavazzana M, Chen Z, Cohen ÉA, Corbelli GM, Eholié S, Eyal N, Fidler S, Garcia L, Grossman C, Henderson G, Henrich TJ, Jefferys R, Kiem HP, McCune J, Moodley K, Newman PA, Nijhuis M, Nsubuga MS, Ott M, Palmer S, Richman D, Saez-Cirion A, Sharp M, Siliciano J, Silvestri G, Singh J, Spire B, Taylor J, Tolstrup M, Valente S, van Lunzen J, Walensky R, Wilson I, Zack J.
Nat Med. 2016 Aug;22(8):839-50. doi: 10.1038/nm.4108.
Epub 2016 Jul 11.PMID: 27400264

HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART.
Ananworanich J, Chomont N, Eller LA, Kroon E, Tovanabutra S, Bose M, Nau M, Fletcher JL, Tipsuk S, Vandergeeten C, O’Connell RJ, Pinyakorn S, Michael N, Phanuphak N, Robb ML; RV217 and RV254/SEARCH010 study groups.
EBioMedicine. 2016 Sep;11:68-72. doi: 10.1016/j.ebiom.2016.07.024.
Epub 2016 Jul 20. PMID: 27460436

Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
Sereti I, Krebs SJ, Phanuphak N, Fletcher JL, Slike B, Pinyakorn S, O’Connell RJ, Rupert A, Chomont N, Valcour V, Kim JH, Robb ML, Michael NL, Douek DC, Ananworanich J, Utay NS; RV254/SEARCH 010, RV304/SEARCH 013 and SEARCH 011 protocol teams.
Clin Infect Dis. 2017 Jan 15;64(2):124-131. doi: 10.1093/cid/ciw683.
Epub 2016 Oct 12. PMID: 27737952

Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok.
Kroon EDMB, Phanuphak N, Shattock AJ, Fletcher JLK, Pinyakorn S, Chomchey N, Akapirat S, de Souza MS, Robb ML, Kim JH, van Griensven F, Ananworanich J, Wilson DP. J
Int AIDS Soc. 2017 Jun 28;20(1):1-9. doi: 10.7448/IAS.20.1.21708. PMID: 28691441